HemosIL VWF:GPIbR Assay Has a Greater Sensitivity than VWF:RCo Technique to Detect Acquired von Willebrand Syndrome in Myeloproliferative Neoplasms.
Pierre LaporteMarie TuffigoAnne RymanMathieu FioreEtienne RivièreChloé JamesAlexandre GuyPublished in: Thrombosis and haemostasis (2022)
Evaluation of VWF:Act using VWF:GPIbR has a greater sensitivity compared with aggregometry to detect AVWS in T-MPN patients.